1. Globalization, intellectual property rights, and pharmaceuticals: meeting the challenges to addressing health gaps in the new international environment&Kenneth C. Shadlen, Samira Guennif Alenka Guzmán and N. Lalitha 1
2. Pharmaceutical production and access to essential medicines in South Africa&Heinz Klug 29
3. Intellectual property and access to medicines: paradoxes in Moroccan policy&Ga？lle Krikorian 56
4. The invisible threat: trade, intellectual property, and pharmaceutical regulations in Colombia&Tatiana Andia 77
5. The challenges of constructing pharmaceutical capabilities and promoting access to medicines in Mexico under TRIPS&Alenka Guzmán 110
6. Corporate power and state resistance: Brazil's use of TRIPS flexibilities for its National AIDS Program&Matthew Flynn 149
7. The politics of patents and drugs in Brazil and Mexico: the industrial bases of health policies&Kenneth C. Shadlen 178
8. Pharmaceutical patent policy in developing countries: learning from the Canadian experience&Jean-Frédéric Morin and Mélanie Bourassa Forcier 202
9. Access to Indian generic drugs: emerging issues&N. Lalitha 225
10. Sufficient but expensive drugs: a double-track system that facilitated supply capability in China&Mariko Watanabe and Luwen Shi 253
11. Access to essential drugs in Thailand: intellectual property rights and other institutional matters affecting public health in a developing country&Samira Guennif 286
12. The TRIPS agreement and health innovation in Bangladesh&Padmashree Gehl Sampath 310
Index 325